Topical metronidazole in the treatment of rosacea.
Veien Nk, Jørgen V. Christiansen, NIELS HJORTH, Henning Schmidt
Abstract
Veien Nk, Jørgen V. Christiansen, NIELS HJORTH, Henning Schmidt
Abstract
One percent metronidazole in an emollient cream base was compared with 250 mg oral tetracycline taken twice daily for the treatment of seventy-five patients with rosacea. After eight weeks of treatment there was no statistically significant difference between the results of the two treatments. Tetracycline did have a more rapid onset of effect on papules and pustules. Both treatments were well tolerated.
OpenAlex reports 39 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
One percent metronidazole in an emollient cream base was compared with 250 mg oral tetracycline taken twice daily for the treatment of seventy-five patients with rosacea. After eight weeks of treatment there was no statistically significant difference between the results of the two treatments. Tetracycline did have a more rapid onset of effect on papules and pustules. Both treatments were well tolerated.
Key concepts: Rosacea, Medicine, Metronidazole, Tetracycline, Dermatology, Significant difference, Acne, Antibiotics